Homology, similarity, and identity in peptide epitope immunodefinition

Journal of Peptide Science

Volumn 18, Issue 8, 2012, Pages 487-494

  Kanduc, Darja ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Homology; Identity; Peptide epitopes; Sequence similarity analysis; Similarity

Indexed keywords

EPITOPE; PENTAPEPTIDE; PROTEOME;

AMINO ACID SEQUENCE; ARTICLE; CYTOLOGY; HUMAN; IMMUNOLOGY; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; VESICULAR STOMATITIS VIRUS;

AMINO ACID SEQUENCE; ANIMALS; EPITOPES; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDES;

EID: 84864013251     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.2419     Document Type: Article

References (128)

1. Reeck GR, de Haen C, Teller DC, Doolittle RF, Fitch WM, Dickerson RE, Chambon P, McLachlan AD, Margoliash E, Jukes TH, Zuckerhandl E. "Homology" in proteins and nucleic acids: a terminology muddle and a way out of it. Cell 1987; 50: 667
2. Lewin R. When does homology mean something else? Science 1987; 237: 1570.
3. Kimelberg HK. 'Homology' controversy. Science 1987; 238: 1217.
4. Dover G. Nonhomologous views of a terminology muddle. Cell 1987; 51: 515-516.
5. Aboitiz F. Nonhomologous views of a terminology muddle. Cell 1987; 51: 515-516.
6. Wegnez M. Nonhomologous views of a terminology muddle. Cell 1987; 51: 515-516.
7. Kluge AG. The repugnant and the mature in phylogenetic inference: atemporal similarity and historical identity. Cladistics 2003; 19: 3565-3568.
8. Tauber AI. Immunology and the enigma of selfhood. In Growing Explanations: Historical Perspectives on the Sciences of Complexity, Norton Wise M (ed). Duke University Press: Durham, NC, 2004; 275-300.
9. Lucchese A, Stevanovic S, Sinha AA, Mittelman A, Kanduc D. Role of MHC II affinity and molecular mimicry in defining anti-HER-2/neu MAb-3 linear peptide epitope. Peptides 2003; 24: 193-197.
10. Tiwari R, Geliebter J, Lucchese A, Mittelman A, Kanduc D. Computational peptide dissection of Melan-a/MART-1 oncoprotein antigenicity. Peptides 2004; 25: 1865-1871.
11. Mittelman A, Tiwari R, Lucchese G, Willers J, Dummer R, Kanduc D. Identification of monoclonal anti-HMW-MAA antibody linear peptide epitope by proteomic database mining. J. Invest. Dermatol. 2004; 123: 670-675.
12. Willers J, Lucchese A, Mittelman A, Dummer R, Kanduc D. Definition of anti-tyrosinase MAb T311 linear determinant by proteome-based similarity analysis. Exp. Dermatol. 2005; 14: 543-550.
13. Stufano A, Kanduc D. Proteome-based epitopic peptide scanning along PSA. Exp. Mol. Pathol. 2009; 86: 36-40.
14. Lucchese A, Mittelman A, Lin MS, Kanduc D, Sinha AA. Epitope definition by proteomic similarity analysis: identification of the linear determinant of the anti-Dsg3 MAb 5H10. J. Transl. Med. 2004; 2: 43.
15. Lucchese A, Mittelman A, Tessitore L, Serpico R, Sinha AA, Kanduc D. Proteomic definition of a desmoglein linear determinant common to Pemphigus vulgaris and Pemphigus foliaceous. J. Transl. Med. 2006; 4: 37.
16. Angelini G, Bonamonte D, Lucchese A, Favia G, Serpico R, Mittelman A, Simone S, Sinha AA, Kanduc D. Preliminary data on Pemphigus vulgaris treatment by a proteomics-defined peptide: a case report. J. Transl. Med. 2006; 4: 43.
17. Claverie JM, Kourilsky P, Langlade-Demoyen P, Chalufour-Prochnicka A, Dadaglio G, Tekaia F, Plata F, Bougueleret L. T-immunogenic peptides are constituted of rare sequence patterns. Use in the identification of T epitopes in the human immunodeficiency virus gag protein. Eur. J. Immunol. 1988; 18: 1547-1553.
18. Maksyutov AZ, Bachinskii AG, Bazhan SI, Ryzhikov EA, Maksyutov ZA. Exclusion of HIV epitopes shared with human proteins is prerequisite for designing safer AIDS vaccines. J. Clin. Virol. 2004; 31: S26-S38.
19. Rolland M, Nickle DC, Deng W, Frahm N, Brander C, Learn GH, Heckerman D, Jojic N, Jojic V, Walker BD, Mullins JI. Recognition of HIV-1 peptides by host CTL is related to HIV-1 similarity to human proteins. PLoS One 2007; 2: e823.
20. Kanduc D, Tessitore L, Lucchese G, Kusalik A, Farber E, Marincola FM. Sequence uniqueness and sequence variability as modulating factors of human anti-HCV humoral immune response. Cancer Immunol. Immunother. 2008; 57: 1215-1223.
21. Polimeno L, Mittelman A, Gennero L, Ponzetto A, Lucchese G, Stufano A, Kusalik A, Kanduc D. Sub-epitopic dissection of HCV E1315-328HRMAWDMMMNWSPT sequence by similarity analysis. Amino Acids 2008; 34: 479-484.
22. Tauber AI. The biological notion of self and nonself. Stanford encyclopedia of science, 2009.
23. Kanduc D. The self-nonself issue: a confrontation between proteomes. Self Nonself 2010; 1: 255-258.
24. Vita R, Zarebski L, Greenbaum JA, Emami H, Hoof I, Salimi N, Damle R, Sette A, Peters B. The immune epitope database 2.0. Nucleic Acids Res. 2010; 38: D854-D862.
25. Kuiken C, Leitner T, Foley B, Hahn B, Marx P, McCutchan F, Wolinsky S, Korber B. HIV sequence compendium. LA-UR 09-03280. Los Alamos National Laboratory, NM, 2009.
26. Kuiken C, Foley B, Leitner T, Apetrei C, Hahn B, Mizrachi I, Mullins J, Rambaut A, Wolinsky S, Korber B. HIV sequence compendium. LA-UR 10-03684. Los Alamos National Laboratory, NM, 2010.
27. Ivanciuc O, Schein CH, Braun W. SDAP: database and computational tools for allergenic proteins. Nucleic Acids Res. 2003; 31: 359-362.
28. Kanduc D, Lucchese A, Mittelman A. Non-redundant peptidomes from DAPs: towards "the vaccine"? Autoimmun. Rev. 2007; 6: 290-294
29. Amela I, Cedano J, Querol E. Pathogen proteins eliciting antibodies do not share epitopes with host proteins: a bioinformatics approach. PLoS One 2007; 2: e512.
30. Berglund L, Andrade J, Odeberg J, Uhlén M. The epitope space of the human proteome. Protein Sci. 2008; 17: 606-613.
31. Kanduc D. Correlating low-similarity peptide sequences and allergenic epitopes. Curr. Pharm. Des. 2008; 14: 289-295.
32. Kanduc D, Serpico R, Lucchese A, Shoenfeld Y. Correlating low-similarity peptide sequences and HIV B-cell epitopes. Autoimmun. Rev. 2008; 7: 291-296.
33. Lucchese G, Stufano A, Kanduc D. Proteome-guided search for influenza A B-cell epitopes. FEMS Immunol. Med. Microbiol. 2009; 57: 88-92.
34. Lucchese A, Serpico R, Crincoli V, Shoenfeld Y, Kanduc D. Sequence uniqueness as a molecular signature of HIV-1-derived B-cell epitopes. Int. J. Immunopathol. Pharmacol. 2009; 22: 639-646.
35. Lucchese G, Stufano A, Kanduc D. Proposing low-similarity peptide vaccines against Mycobacterium tuberculosis. J. Biomed. Biotechnol. 2010; 832341.
36. Stufano A, Capone G, Pesetti B, Polimeno L, Kanduc D. Clustering of rare peptide segments in the HCV immunome. Self Nonself 2010; 1: 154-162.
37. Lucchese G, Stufano A, Calabrò M, Kanduc D. Charting the peptide crossreactome between HIV-1 and the human proteome. Front. Biosci. 2011; 3: 1385-1400.
38. Lucchese G, Calabrò M, Kanduc D. Circumscribing the conformational peptide epitope landscape. Curr. Pharm. Des. 2012; 18: 832-839.
39. Lucchese G. Confronting JC virus and Homo sapiens biological signatures. Front. Biosci. 2012; In press
40. Lucchese G, Stufano A, Kanduc D. Searching for an effective, safe and universal anti-HIV vaccine: finding the answer in just one short peptide. Self Nonself 2011; 2: 49-54.
41. Lucchese G, Pesce Delfino A. Using proteomics to develop an anti-Campylobacter jejuni vaccine. Immunopharmacol. Immunotoxicol. 2012; doi: 10.3109/08923973.2011.608685.
42. Fasano C, Kanduc D. Selfness-nonselfness in designing an anti-B19 erythrovirus vaccine. Self Nonself 2011; 2: 114-119.
43. Kanduc D. Epitopic peptides with low similarity to the host proteome: towards biological therapies without side effects. Expert Opin. Biol. Ther. 2009; 9: 45-53.
44. Kanduc D. Peptide cross-reactivity: the original sin of vaccines. Front. Biosci. 2012; 4: 1393-1401.
45. Brigandt I. Accounting for vertebrate limbs: from Owen's homology to novelty in evo-devo. Philos. Theor. Biol. 2009; 1: e004
46. Sander C, Schneider R. Database of homology-derived protein structures and the structural meaning of sequence alignment. Proteins 1991; 9: 56-68.
47. Gill DS, Banerjee AK. Vesicular stomatitis virus NS proteins: structural similarity without extensive sequence homology. J. Virol. 1985; 55: 60-66.
48. Yura K, Shionyu M, Kawatani K, Go M. Repetitive use of a phosphate-binding module in DNA polymerase beta, Oct-1 POU domain and phage repressors. Cell. Mol. Life Sci. 1999; 55: 472-486.
49. Brenner SE. A tour of structural genomics. Nat. Rev. Genet. 2001; 2: 801-809.
50. Bauer F, Schweimer K, Klüver E, Conejo-Garcia JR, Forssmann WG, Rösch P, Adermann K, Sticht H. Structure determination of human and murine beta-defensins reveals structural conservation in the absence of significant sequence similarity. Protein Sci. 2001; 10: 2470-2479.
51. Fribourg S, Conti E. Structural similarity in the absence of sequence homology of the messenger RNA export factors Mtr2 and p15. EMBO Rep. 2003; 4: 699-703.
52. Karchin R, Cline M, Mandel-Gutfreund Y, Karplus K. Hidden Markov models that use predicted local structure for fold recognition: alphabets of backbone geometry. Proteins 2003; 51: 504-514.
53. Nielsen M, Lundegaard C, Lund O, Petersen TN. CPHmodels-3.0-remote homology modeling using structure-guided sequence profiles. Nucleic Acids Res. 2010; 38: W576-W581.
54. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994; 22: 4673-4680.
55. Campanella JJ, Bitincka L, Smalley J. MatGAT: an application that generates similarity/identity matrices using protein or DNA sequences. BMC Bioinformatics 2003; 4: 29.
56. Nair R, Rost B. Sequence conserved for subcellular localization. Protein Sci. 2002; 11: 2836-2847.
57. May AC. Percent sequence identity; the need to be explicit. Structure 2004; 12: 737-738.
58. Balaji S, Srinivasan N. Use of a database of structural alignments and phylogenetic trees in investigating the relationship between sequence and structural variability among homologous proteins. Protein Eng. 2001; 14: 219-226.
59. Pérez-Rueda E, Segovia L. Protein homology detection and fold inference through multiple alignment entropy profiles. Proteins 2008; 70: 248-256.
60. Simossis VA, Heringa J. Integrating protein secondary structure prediction and multiple sequence alignment. Curr. Protein Pept. Sci. 2004; 5: 249-266.
61. Webber C, Ponting CP. Genes and homology. Curr. Biol. 2004; 14: R332-R333.
62. DeMattei CR, Davis CP, Konopka JB. Point mutations identify a conserved region of the Saccharomyces cerevisiae AFR1 gene that is essential for both the pheromone signaling and morphogenesis functions. Genetics 2000; 155: 43-55.
63. Kang L, Wu KP, Vendruscolo M, Baum J. The A53T mutation is key in defining the differences in the aggregation kinetics of human and mouse α-synuclein. J. Am. Chem. Soc. 2011; 133: 13465-13470.
64. Guo W, Chen Y, Zhou X, Kar A, Ray P, Chen X, Rao EJ, Yang M, Ye H, Zhu L, Liu J, Xu M, Yang Y, Wang C, Zhang D, Bigio EH, Mesulam M, Shen Y, Xu Q, Fushimi K, Wu JY. An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity. Nat. Struct. Mol. Biol. 2011; 18: 822-830.
65. Davey KM, Parboosingh JS, McLeod DR, Chan A, Casey R, Ferreira P, Snyder FF, Bridge PJ, Bernier FP. Mutation of DNAJC19, a human homologue of yeast inner mitochondrial membrane co-chaperones, causes DCMA syndrome, a novel autosomal recessive Barth syndrome-like condition. J. Med. Genet. 2006; 43: 385-393.
66. Dagvadorj A, Olivé M, Urtizberea JA, Halle M, Shatunov A, Bönnemann C, Park KY, Goebel HH, Ferrer I, Vicart P, Dalakas MC, Goldfarb LG. A series of West European patients with severe cardiac and skeletal myopathy associated with a de novo R406W mutation in desmin. J. Neurol. 2004; 251: 143-149.
67. Henriksen C, Madsen LB, Bendixen C, Larsen K. Characterization of the porcine TOR1A gene: the first step towards generation of a pig model for dystonia. Gene 2009; 430: 105-115.
68. Doyle JL, DeSilva U, Miller W, Green ED. Divergent human and mouse orthologs of a novel gene (WBSCR15/Wbscr15) reside within the genomic interval commonly deleted in Williams syndrome. Cytogenet. Cell Genet. 2000; 90: 285-290.
69. Giles K, Glidden DV, Patel S, Korth C, Groth D, Lemus A, DeArmond SJ, Prusiner SB. Human prion strain selection in transgenic mice. Ann. Neurol. 2010; 68: 151-161.
70. Cho MH, Corea OR, Yang H, Bedgar DL, Laskar DD, Anterola AM, Moog-Anterola FA, Hood RL, Kohalmi SE, Bernards MA, Kang C, Davin LB, Lewis NG. Phenylalanine biosynthesis in Arabidopsis thaliana. Identification and characterization of arogenate dehydratases. J. Biol. Chem. 2007; 282: 30827-30835.
71. Del Sol A, Fujihashi H, Amoros D, Nussinov R. Residue centrality, functionally important residues, and active site shape: analysis of enzyme and non-enzyme families. Protein Sci. 2006; 15: 2120-2128.
72. Goodey NM, Herbert KG, Hall SM, Bagley KC. Prediction of residues involved in inhibitor specificity in the dihydrofolate reductase family. Biochim. Biophys. Acta 2011; 1814: 1870-1879.
73. Sheinerman FB, Al-Lazikani B, Honig B. Sequence, structure and energetic determinants of phosphopeptide selectivity of SH2 domains. J. Mol. Biol. 2003; 334: 823-841.
74. La D, Silver M, Edgar RC, Livesay DR. Using motif-based methods in multiple genome analyses: a case study comparing orthologous mesophilic and thermophilic proteins. Biochemistry 2003; 42: 8988-8998.
75. Ahmad S, Gromiha MM, Sarai A. Prediction of DNA binding in proteins from composition, sequence and structure. Genome Inf. 2002; 13: 308-9.
76. Wang L, Brown SJ. Prediction of DNA-binding residues from sequence features. J. Bioinform. Comput. Biol. 2006; 4: 1141-1158
77. Lei Z, Dai Y. A novel approach for prediction of protein subcellular localization from sequence using Fourier analysis and support vector machines. In Proceedings of 4th ACM SIGKDD Workshop on Data Mining in Bioinformatics, Seattle, 2004; 11-17.
78. Morrison DA, Ellis J, Johnson AM. An empirical comparison of distance matrix techniques for estimating codon usage divergence. J. Mol. Evol. 1994; 39: 533-536.
79. Davey NE, Van Roey K, Weatheritt RJ, Toedt G, Uyar B, Altenberg B, Budd A, Diella F, Dinkel H, Gibson TJ. Attributes of short linear motifs. Mol. Biosyst. 2012; 8: 268-281.
80. Chica C, Labarga A, Gould CM, Lopez R, Gibson TJ. A tree-based conservation scoring method for short linear motifs in multiple alignments of protein sequences. BMC Bioinformatics 2008; 9: 229.
81. Puntervoll P, Linding R, Gemünd C, Chabanis-Davidson S, Mattingsdal M, Cameron S, Martin DM, Ausiello G, Brannetti B, Costantini A, Ferrè F, Maselli V, Via A, Cesareni G, Diella F, Superti-Furga G, Wyrwicz L, Ramu C, McGuigan C, Gudavalli R, Letunic I, Bork P, Rychlewski L, Küster B, Helmer-Citterich M, Hunter WN, Aasland R, Gibson TJ. ELM server: a new resource for investigating short functional sites in modular eukaryotic proteins. Nucleic Acids Res. 2003; 31: 3625-3630.
82. D'Souza SE, Ginsberg MH, Plow EF. Arginyl-glycyl-aspartic acid (RGD): a cell adhesion motif. Trends Biochem. Sci. 1991; 16: 246-250.
83. Jimenez B, Ugwu F, Zhao R, Orti L, Makhnevych T, Pineda-Lucena A, Houry WA. The structure of the minimal tetratricopeptide repeat domain protein Tah1 reveals the mechanism of its interaction with Pih1 and Hsp90. J. Biol. Chem. 2012; 287: 5698-5709.
84. The UniProt Consortium. Ongoing and future developments at the Universal Protein Resource. Nucleic Acids Res. 2011; 39: D214-D219.
85. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J. Mol. Biol. 1990; 215: 403-410.
86. Mount DW. Using the Basic Local Alignment Search Tool (BLAST). CSH Protoc. 2007; pdb.top17.
87. Enard W, Przeworski M, Fisher SE, Lai CS, Wiebe V, Kitano T, Monaco AP, Pääbo S. Molecular evolution of FOXP2, a gene involved in speech and language. Nature 2002; 418: 869-872.
88. Lucchese G, Stufano A, Trost B, Kusalik A, Kanduc D. Peptidology: short amino acid modules in cell biology and immunology. Amino Acids 2007; 33: 703-707.
89. Kanduc D. Protein information content resides in rare peptide segments. Peptides 2010; 31: 983-938.
90. Zeng W, Pagnon J, Jackson DC. The C-terminal pentapeptide of LHRH is a dominant B cell epitope with antigenic and biological function. Mol. Immunol. 2007; 44: 3724-3731.
91. Rothbard JB, Gefter ML. Interactions between immunogenic peptides and MHC proteins. Annu. Rev. Immunol. 1991; 9: 527-565.
92. Liebers V, Raulf M, Mazur G, Modrow S Baur, X. Epitope mapping with peptides of Chi t I component III and immunomodulation of the Chi t immune response. J. Allergy Clin. Immunol. 1993; 92: 334-339.
93. Moran E, Simmons C, Vinh Chau N, Luhn K, Wills B, Dung NP, Thao le TT, Hien TT, Farrar J, Rowland-Jones S, Dong T. Preservation of a critical epitope core region is associated with the high degree of flaviviral cross-reactivity exhibited by a dengue-specific CD4+ T-cell clone. Eur. J. Immunol. 2008; 38: 1050-1057.
94. Godkin AJ, Thomas HC, Openshaw PJ. Evolution of epitope-specific memory CD4(+) T-cells after clearance of hepatitis C virus. J. Immunol. 2002; 169: 2210-2214.
95. Reddehase MJ, Rothbard JB, Koszinowski UH. A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature 1989; 337: 651-653.
96. Gulden PH, Fischer P 3rd, Sherman NE, Wang W, Engelhard VH, Shabanowitz J, Hunt DF, Pamer EG. A Listeria monocytogenes pentapeptide is presented to cytolytic T lymphocytes by the H2-M3 MHC class Ib molecule. Immunity 1996; 5: 73-79.
97. Zagury JF, Bernard J, Achour A, Astgen A, Lachgar A, Fall L, Carelli C, Issing W, Mbika JP, Cantalloube H, Picard O, Gourbil A, Guignon JM, Cozette J, Carlotti M, Callebaut I, Mornon JP, Burny A, Feldman M, Bizzini B, Zagury D. HIV-1-induced immune suppression may result from autoimmune disorders including anti-SLWDQ autoantibodies. Biomed. Pharmacother. 1993; 47: 93-99.
98. Brown LM, Papa RA, Frost MJ, Mackintosh SG, Gu X, Dixon RJ, Shannon AD. A single amino acid is critical for the expression of B-cell epitopes on the helicase domain of the pestivirus NS3 protein. Virus Res. 2002; 84: 111-124.
99. Smilek DE, Wraith DC, Hodgkinson S, Dwivedy S, Steinman L, McDevitt HO. A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 1991; 88: 9633-9637.
100. Fleischhauer K, Avila D, Vilbois F, Traversari C, Bordignon C, Wallny HJ. Characterization of natural peptide ligands for HLA-B*4402 and -B*4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLA-B44 heavy chain. Tissue Antigens 1994; 44: 311-317.
101. Yagüe J, Vázquez J, López de Castro JA. A single amino acid change makes the peptide specificity of B*3910 unrelated to B*3901 and closer to a group of HLA-B proteins including the malaria-protecting allotype HLA-B53. Tissue Antigens 1998; 52: 416-421.
102. Hartman AL, Ling L, Nichol ST, Hibberd ML. Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein. J. Virol. 2008; 82: 5348-5358.
103. Lucchese G, Sinha AA, Kanduc D. How a single amino acid change may alter the immunological information of a peptide. Front. Biosci. 2012; 4: 1843-1852.
104. Eggleton P, Haigh R, Winyard PG. Consequence of neo-antigenicity of the 'altered self'. Rheumatology (Oxford) 2008; 47: 567-571.
105. Dowling W, Thompson E, Badger C, Mellquist JL, Garrison AR, Smith JM, Paragas J, Hogan RJ, Schmaljohn C. Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of ebola virus GP DNA vaccines. J. Virol. 2007; 81: 1821-1837.
106. Tatsumi Y, Sasahara Y, Kohyama N, Ayano S, Endo M, Yoshida T, Yamada K, Totsuka M, Hattori M. Introducing site-specific glycosylation using protein engineering techniques reduces the immunogenicity of β-lactoglobulin. Biosci. Biotechnol. Biochem. 2012; 76: 478-485.
107. Ilchmann A, Burgdorf S, Scheurer S, Waibler Z, Nagai R, Wellner A, Yamamoto Y, Yamamoto H, Henle T, Kurts C, Kalinke U, Vieths S, Toda M. Glycation of a food allergen by the Maillard reaction enhances its T-cell immunogenicity: role of macrophage scavenger receptor class A type I and II. J. Allergy Clin. Immunol. 2010; 125: 175-183.e1-11.
108. Ma BJ, Alam SM, Go EP, Lu X, Desaire H, Tomaras GD, Bowman C, Sutherland LL, Scearce RM, Santra S, Letvin NL, Kepler TB, Liao HX, Haynes BF. Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies. PLoS Pathog. 2011; 7: e1002200.
109. Wu CH, Yeh LS, Huang H, Arminski L, Castro-Alvear J, Chen Y, Hu Z, Kourtesis P, Ledley RS, Suzek BE, Vinayaka CR, Zhang J, Barker WC. The Protein Information Resource. Nucleic Acids Res. 2003; 31: 345-347.
110. Kanduc D. Peptimmunology: immunogenic peptides and sequence redundancy. Curr. Drug Discov. Technol. 2005; 2: 239-244.
111. Trost B, Kusalik A, Lucchese G, Kanduc D. Bacterial peptides are intensively present throughout the human proteome. Self Nonself 2010; 1: 71-74.
112. Trost B, Lucchese G, Stufano A, Bickis M, Kusalik A, Kanduc D. No human protein is exempt from bacterial motifs. Not even one. Self Nonself 2010; 1: 328-334.
113. Kanduc D. Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes. Biologics 2010; 4: 245-261.
114. Kanduc D. Defining peptide sequences: from antigenicity to immunogenicity through redundancy. Curr. Pharmacogenomics 2006; 4: 33-37.
115. Wood R, Lawn SD, Johnstone-Robertson S, Bekker LG. Tuberculosis control has failed in South Africa - time to reappraise strategy. S. Afr. Med. J. 2011; 101: 111-114.
116. Overwijk WW, Restifo NP. Autoimmunity and the immunotherapy of cancer: targeting the "self" to destroy the "other". Crit. Rev. Immunol. 2000; 20: 433-450.
117. Dudley ME, Wunderlich JR, Robbins PF, Yang JC, Hwu P, Schwartzentruber DJ, Topalian SL, Sherry R, Restifo NP, Hubicki AM, Robinson MR, Raffeld M, Duray P, Seipp CA, Rogers-Freezer L, Morton KE, Mavroukakis SA, White DE, Rosenberg SA. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 2002; 298: 850-854.
118. Phan GQ, Yang JC, Sherry RM, Hwu P, Topalian SL, Schwartzentruber DJ, Restifo NP, Haworth LR, Seipp CA, Freezer LJ, Morton KE, Mavroukakis SA, Duray PH, Steinberg SM, Allison JP, Davis TA, Rosenberg SA. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc. Natl. Acad. Sci. USA 2003; 100: 8372-8377.
119. Koon H, Atkins M. Autoimmunity and immunotherapy for cancer. N. Engl. J. Med. 2006; 354: 758-760.
120. Mandavilli A. When the vaccine causes disease. Nat. Med. 2007; 13: 274.
121. Caspi RR. Immunotherapy of autoimmunity and cancer: the penalty for success. Nat. Rev. Immunol. 2008; 8: 970-976.
122. Higgins JP, Bernstein MB, Hodge JW. Enhancing immune responses to tumor-associated antigens. Cancer Biol. Ther. 2009; 8: 1440-1449.
123. Fernandes RC, Medina-Acosta E. Disseminated BCG disease and the full contraindication to BCG vaccination for children exposed to and/or infected by HIV. Int. J. Tuberc. Lung Dis. 2009; 13: 1188-1189.
124. Amos SM, Duong CP, Westwood JA, Ritchie DS, Junghans RP, Darcy PK, Kershaw MH. Autoimmunity associated with immunotherapy of cancer. Blood 2011; 118: 499-509.
125. Toplak N, Avcin T. Influenza and autoimmunity. Ann. N. Y. Acad. Sci. 2009; 1173: 619-626.
126. de Carvalho JF, Pereira RM, Shoenfeld Y. The mosaic of autoimmunity: the role of environmental factors. Front. Biosci. 2009; 1: 501-509.
127. Jacob JB, Kong YC, Nalbantoglu I, Snower DP, Wei WZ. Tumor regression following DNA vaccination and regulatory T cell depletion in neu transgenic mice leads to an increased risk for autoimmunity. J. Immunol. 2009; 182: 5873-5881.
128. Kong YC, Jacob JB, Flynn JC, Elliott BE, Wei WZ. Autoimmune thyroiditis as an indicator of autoimmune sequelae during cancer immunotherapy. Autoimmun. Rev. 2009; 9: 28-33.